AI biotech Xaira unveils virtual cell research papernews2025-06-17T16:00:23+00:00June 17th, 2025|Endpoints News|
Alphabet-backed Isomorphic Labs to open US office, hires ex-Relay CMOnews2025-06-17T11:30:14+00:00June 17th, 2025|Endpoints News|
AstraZeneca, CSPC ink AI drug development deal for $110M upfront news2025-06-13T10:58:25+00:00June 13th, 2025|Endpoints News|
Endpoints Livestream: What happens when AI thinks in ways we can’t understand?news2025-06-11T15:32:23+00:00June 11th, 2025|Endpoints News|
Basecamp Research CEO on fixing the ‘data wall’ in AI bionews2025-06-11T09:30:06+00:00June 11th, 2025|Endpoints News|
Recursion to lay off 20% of staff, a month after slashing its pipelinenews2025-06-10T11:08:39+00:00June 10th, 2025|Endpoints News|
MIT scientists debut AI model Boltz-2 that predicts drug binding affinitynews2025-06-06T13:30:35+00:00June 6th, 2025|Endpoints News|
Post-Hoc: AI bio needs to heed the overhyped history of CRISPRnews2025-05-22T11:00:10+00:00May 22nd, 2025|Endpoints News|
Pathos AI collects $365M to fuel data-driven oncology studiesnews2025-05-15T14:44:09+00:00May 15th, 2025|Endpoints News|
Exclusive: Datavant will acquire Aetion, double life sciences teamnews2025-05-15T12:30:38+00:00May 15th, 2025|Endpoints News|
